|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03869 HOSPITAL CORP
Nominal 
6.870 +0.040 (+0.586%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 743,044 | 3.272% | 1,442,292 | 1,427,733 | 1,142,951 | 520,290 |
| Cost of Sales | (595,992) | 5.136% | (1,166,473) | (1,188,373) | (992,073) | (306,063) |
| Gross Profit | 147,052 | -3.651% | 275,819 | 239,360 | 150,878 | 214,227 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (21) | 884 | (462,150) | (578,458) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 201,247 | 238.139% | 61,269 | 216,204 | (532,628) | (449,102) | |
| Taxation | (32,627) | -9.238% | (47,479) | (47,860) | 4,031 | 86,706 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (14,903) | -66.294% | (52,418) | (36,960) | 47,649 | 81,687 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 153,717 | -- | (38,628) | 131,384 | (480,948) | (280,709) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (106,719) | -- | 120,592 | (88,366) | (5,360) | 14,028 |
| Depreciation & Amortisation | 32,684 | 3.934% | 63,107 | 68,613 | 63,279 | 41,145 |
| Directors' Emoluments | -- | -- | 2,303 | 2,262 | 6,389 | 5,069 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 113.000 | -- | -28.200 | 95.600 | -348.000 | -203.100 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 1.547 | 0.611 | 1.036 | 0.963 |
| NBV per share ($) | 3.679 | -- | 2.444 | 2.743 | 1.850 | 5.774 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 153,717 |
| %Change | -- |
| EPS / (LPS) | RMB 1.130 |
| NBV Per Share (¥) | RMB 3.679 |